Report Overview

The Australian HIV drug market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

In 2019, approximately 0.1% of the total population of Australia had HIV 2019. HIV is a virus that can damage the immune system and make it difficult for the body to fight off simple infections. HIV is not the same as AIDS. If left untreated, HIV can lead to AIDS. However, with highly effective HIV treatments now available, AIDS is extremely rare in Australia. HIV is spread through body fluids including blood, semen, vaginal fluids, anal mucus, and breastmilk, and from mother to child. HIV cannot be spread through saliva or kissing, hugging, or shaking hands, toilet seats, insect bites, sharing cutlery or crockery, or by eating food prepared by someone who is HIV-positive. The increasing awareness regarding the severity of HIV AIDS has created a huge emphasis on several drugs, related to the treatment of this disease. The side effects of HIV/AIDS have led to several drug innovations, particularly aimed at the efficient treatment of patients with advanced stages of the disease. The report encompasses several factors that have contributed to the growth of the market in recent years.



Market Drivers

The market is majorly driven by increasing drug approvals, High prevalence of HIV/AIDS. The increasing emphasis on the research and development of HIV/AIDS drugs has led to several drug innovations in recent years. The increasing demand for therapeutic procedures and treatment methods has created a subsequent emphasis on the development of related drugs. The rising prevalence of HIV/AIDS has resulted in an increased emphasis on the development of treatment methods and drugs associated with the treatment of this disease. Due to the increasing incidence of HIV/AIDS, HIV/AIDS drug companies have witnessed massive growth opportunities in recent years.

Epidemiology of HIV

In 2019, it was estimated that there were 29,045 people withHIVinAustralia. Of these 29,045 people, an estimated 90% were diagnosed by the end of 2019. The research also shows that 91% of people diagnosed were receivingHIVtreatment, and of those on treatment, 97% had an undetectable viral load.

The number of HIV notifications newly diagnosed in Australia has remained stable from 2012-2016, with 1013 new diagnoses in 2016. 26,444(0.1% of the total population of Australia) people with HIV in 2016. An estimated 7.3% prevalence among gay and bisexual men and an estimated 1.4% prevalence among people who inject drugs.

Of the estimated 26,444 people living with HIV in 2016, 89% were diagnosed by the end of 2016 and of those diagnosed 95% were retained in care, 86% were receiving ART, and of those on ART, 93% had achieved viral suppression.